Vitamin D Supplementation in Primary Hyperparathyroidism: Analysis of Benefits and Hazards
Nutrients · 03.08.2026 · 18 (15) · 2504
DOI: 10.3390/nu18152504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 03.08.2026. Verfasst von Thomas Audet und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0C1, Canada. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Vitamin D, Vitamin D Deficiency, Dietary Supplements. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre de recherche de l'Hôpital Maisonneuve-Rosemont, Centre de recherche de l’Hôpital Maisonneuve-Rosemont.
Abstract (Originalsprache)
Primary hyperparathyroidism (PHPT) and vitamin D deficiency (VD) are two frequent medical conditions in the Western world. Purely by dint of their prevalence, these conditions are commonly comorbid. Moreover, they can interact with one another: VD may stimulate PTH secretion, while PHPT may lead to unregulated vitamin D activation from 25-hydroxyvitamin D (25OHD) to 1,25-dihydroxyvitamin D (1,25OH2D), thereby lowering 25OHD levels and further exacerbating VD. Thus, a real conundrum arises: should the careful clinician replete VD in PHPT or not? On the one hand, both conditions could lead to bone mineral density (BMD) loss if untreated, ultimately resulting in osteoporosis and fragility fractures; on the other hand, vitamin D supplementation could lead to further worsening of hypercalcemia and its dreaded complications. To complicate matters, patients undergoing parathyroidectomy (PTX) after long-standing PHPT can also suffer from postoperative hungry-bone syndrome and symptomatic hypocalcemia, which may be further exacerbated by VD. This narrative review aims to summarize the relevant pathophysiological mechanisms underlying these two diseases and their complex interactions. The latest evidence regarding thresholds and targets for vitamin D supplementation in PHPT will be discussed, with a focus on the balance between benefits and risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Department of Medicine, Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0C1, Canada.
- Department of Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada.
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC H2X 0A9, Canada.
- Division of Nephrology, Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada.
- Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada.
- Division of Endocrinology, Hôpital Maisonneuve-Rosemont, Montréal, QC H1T 2M4, Canada.
ORCID-Profile: Thomas Audet
Förderung
- Centre de recherche de l'Hôpital Maisonneuve-Rosemont
- Centre de recherche de l’Hôpital Maisonneuve-Rosemont
Zitieren
APA
Audet, T., Bégin, M. J., Brossard, J. H., Ste-Marie, L. G., Laurin, L. P., Adam, C., Nguyen, T. H. L., & Dupuis, M. E. (2026). Vitamin D Supplementation in Primary Hyperparathyroidism: Analysis of Benefits and Hazards. Nutrients, 18(15), 2504. https://doi.org/10.3390/nu18152504
Vancouver
Audet T, Bégin MJ, Brossard JH, Ste-Marie LG, Laurin LP, Adam C, et al. Vitamin D Supplementation in Primary Hyperparathyroidism: Analysis of Benefits and Hazards. Nutrients. 2026;18(15):2504. doi:10.3390/nu18152504
BibTeX
@article{Audet2026,
author = {Audet, Thomas and Bégin, Marie-Josée and Brossard, Jean-Hugues and Ste-Marie, Louis-Georges and Laurin, Louis-Philippe and Adam, Catherine and Nguyen, Thi Hoang Lan and Dupuis, Marie-Eve},
title = {Vitamin D Supplementation in Primary Hyperparathyroidism: Analysis of Benefits and Hazards},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {15},
pages = {2504},
doi = {10.3390/nu18152504}
}
EUVIMED